University hospital ErlangenfludarabinecyclophosphamideCD19-targeting CAR T cell therapyautoimmune diseasesCD19-targeting CAR T cells
…bed [Müller et al., 2024]. Patients received the therapy at the University hospital Erlangen as part of the CASTLE study [Schett et al., 2024]. Immunosuppre…